← Back to all trials
Not Yet Recruiting
NCT07770334
Procalcitonin as a Prognostic Predictor in Patients With Acute Infectious Disease Hospitalized in the Internal Medicine Department.
Conditions: Procalcitonin, Infection, Internal Medicine Patients
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 1000
Sponsor: Barzilai Medical Center
Summary
Procalcitonin is a well-known biomarker used to distinguish between bacterial and viral infections, assess a patient's risk category, and serve as a prognostic indicator. However, existing data are derived primarily from relatively young patients in intensive care units; there is a lack of information regarding the prognostic significance of procalcitonin in older patients hospitalized in internal medicine wards.
Eligibility Criteria
Inclusion Criteria:
* All patients hospitalized in internal medicine and geriatric wards with a diagnosis of acute infectious disease who underwent procalcitonin testing, starting in 2020.
Exclusion Criteria:
* Age under 18
* Causes for false positive elevated cacitonin:
* Extensive burns
* Major operation in the last 30 days
* Major trauma in the last 30 days.
* Severe pancreatitis
* Cardiogenic shock
* Small Cell Lung Cancer
* Thyroid gland malignancy
Source: ClinicalTrials.gov (NCT07770334). StuddyBuddy aggregates publicly available trial information.